Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Knutson

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Opinion in Molecular Therapeutics|January 24, 2002
Technology evaluation: T-cell activator, XenovaK L Knutson
Endocrinology|September 1, 1994
Identification and subcellular characterization of protein kinase-C isoforms in insulinoma beta-cells and whole isletsK L Knutson, M Hoenig
Journal of Cellular Biochemistry|January 1, 1996
Regulation of distinct pools of protein kinase C delta in beta cellsK L Knutson, M Hoenig
Journal of Cellular Biochemistry|September 15, 1996
Arachidonic acid-induced down-regulation of protein kinase C delta in beta-cellsK L Knutson, M Hoenig
Biochemical Medicine and Metabolic Biology|October 1, 1994
Effect of protein kinase C on the plasma membrane calcium pump in purified beta cellsM Hoenig, K L Knutson
Biochemical and Molecular Medicine|February 12, 1998
Subnuclear localization of protein kinase C delta in beta cellsK L Knutson, M Hoenig
Clinical Breast Cancer|March 20, 2002
Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccineK L Knutson, M L Disis
Clinical and Experimental Immunology|January 24, 2004
IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansionK L Knutson, M L Disis
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 27, 2005
Augmenting T helper cell immunity in cancerK L Knutson, M L Disis
Cancer Immunology, Immunotherapy : CII|July 13, 2005
Tumor antigen-specific T helper cells in cancer immunity and immunotherapyK L Knutson, M L Disis
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Opinion in Molecular Therapeutics|January 24, 2002
Technology evaluation: T-cell activator, XenovaK L Knutson
Endocrinology|September 1, 1994
Identification and subcellular characterization of protein kinase-C isoforms in insulinoma beta-cells and whole isletsK L Knutson, M Hoenig
Journal of Cellular Biochemistry|January 1, 1996
Regulation of distinct pools of protein kinase C delta in beta cellsK L Knutson, M Hoenig
Journal of Cellular Biochemistry|September 15, 1996
Arachidonic acid-induced down-regulation of protein kinase C delta in beta-cellsK L Knutson, M Hoenig
Biochemical Medicine and Metabolic Biology|October 1, 1994
Effect of protein kinase C on the plasma membrane calcium pump in purified beta cellsM Hoenig, K L Knutson
Biochemical and Molecular Medicine|February 12, 1998
Subnuclear localization of protein kinase C delta in beta cellsK L Knutson, M Hoenig
Clinical Breast Cancer|March 20, 2002
Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccineK L Knutson, M L Disis
Clinical and Experimental Immunology|January 24, 2004
IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansionK L Knutson, M L Disis
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 27, 2005
Augmenting T helper cell immunity in cancerK L Knutson, M L Disis
Cancer Immunology, Immunotherapy : CII|July 13, 2005
Tumor antigen-specific T helper cells in cancer immunity and immunotherapyK L Knutson, M L Disis
Pageof 3